Filament Health and Cybin Therapeutics Announce Licensing Agreement

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule...

Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary...

PharmaDrug Announces Resignation of Director

PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care

Mydecine to Launch Special Access Support and Supply Program in Canada...

MYND Life Sciences Announces Collaborative Research Agreement with the University of...

atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for...

PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for...

Load more